CRVS•benzinga•
Corvus Pharmaceuticals Announces Data From Cohorts 1-3 of Placebo-Controlled Phase 1 Clinical Trial Of Soquelitinib In Patients With Moderate To Severe Atopic Dermatitis
Summary
No summary available.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on May 8, 2025 by benzinga